As drug stability requirements grow increasingly stringent, traditional PVC blister with PTP foil packaging can be insufficient for drugs highly sensitive to moisture and oxygen. The combination of Cold Form Aluminum and PTP (Press-Through-Pack) pharmaceutical lidding foil is becoming a key technological solution for superior protection. Αυτό “dual-aluminum” structure provides near-absolute moisture, οξυγόνο, and light barrier properties, significantly extending drug shelf life and enhancing storage/transport safety.
This article systematically analyzes the technical value of this high-grade packaging solution, covering structural principles, υλικές ιδιότητες, core advantages, production processes, and application scenarios.
This is a blister packaging form that uses a cold form aluminum composite as the forming base web, sealed with PTP pharmaceutical aluminum foil. Both contain aluminum layers, creating a “base-lid” dual aluminum foil barrier.
Αποτέλεσμα: Creates a nearly hermetically sealed, independent drug unit wrapped in two layers of aluminum foil.
A composite material designed for deep-draw forming. Typical structure: Outer layer (OPA/PET) / Αλουμινόχαρτο / Inner layer (PVC/PP).
Characteristics: Offers ultimate moisture barrier, oxygen barrier, and light protection, high mechanical strength, suitable for complex blister shapes.
The common lidding material for blister packs. Δομή: Protective print layer / Αλουμίνιο substrate (π.χ., 8011/8021 κράμα) / Heat-seal coating.
The core value of “Cold Form Base + PTP Lid” lies in creating a dual-aluminum barrier system, achieving a leap in performance.
Detailed Advantages:
Production is highly automated on high-speed blister packaging lines:
Unwinding Cold Form Web → Cold Forming (cavity creation) → Automatic Product Feeding → PTP Foil Application & Heat Sealing → Punching into Individual Blisters
Key Process Parameter Control:
This packaging is primarily for drugs that are extremely sensitive to moisture, οξυγόνο, φως, or are high-value, π.χ.:
Selection Basis: Pharmaceutical companies must choose after cost-benefit analysis based on drug stability data, target market climate, and shelf-life requirements.
Ε1: Why is the barrier of Cold Form Alu+PTP far superior to traditional blisters?
ΕΝΑ: It creates a dual aluminum foil barrier (“base-lid”), whereas traditional blisters have only a single aluminum layer in the lid, with a plastic base offering a significantly lower barrier.
Ε2: Which aluminum alloy is commonly used for PTP foil?
ΕΝΑ: Κράμα 8011 is most common, offering good balance of properties and cost. Κράμα 8021 provides higher strength and fewer pinholes for more premium applications.
Ε33: Do all drugs need this packaging?
ΕΝΑ: Not necessarily. It’s primarily for highly sensitive, high-value drugs, or those facing harsh distribution environments. Conventional drugs are adequately served by PVC or PVDC/PVC film with PTP foil.
Ε4: Is this packaging very expensive?
ΕΝΑ: Ναί. Both material costs and equipment requirements are higher than traditional blister packaging. Ωστόσο, it provides top-tier protection for high-value drugs, preventing greater losses due to degradation, offering significant overall benefit.
Ε5: How is this package opened?
ΕΝΑ: Typically via “press-through” opening. The PTP foil is designed for easy peeling; pressing the blister pushes the tablet/capsule through the foil, maintaining seal integrity until use.
Ο “Cold Form Aluminum + PTP Foil” combination represents the premium barrier solution in current solid dosage form blister packaging. Through innovative material science and packaging engineering, it builds a robust protective shield for the most sensitive drugs. As drug development advances and global regulations tighten, this high-end packaging technology, centered on ultimate protection, will play an increasingly critical role in ensuring drug efficacy and patient safety.
